If this box remains here for more than 30 seconds, click this link to try again.
Industries
Functions
Home » Products & Services » Benchmarking Reports » Quality Compliance & Regulatory
Download FREE Excerpt
14 Info Graphics
27 Data Graphics
151 Metrics
28 Narratives
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Buy Now
Industries Profiled: Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device Companies Profiled: Abbott; DRI; Novo Nordisk; Biomarin; Genentech; AstraZeneca; Boehringer Ingelheim; Roche; UCB Pharma; GlaxoSmithKline; Solvay Pharmaceuticals; Stiefel; Pfizer; Lilly; Baxter International; Cephalon; Inc.
Study Snapshot This benchmarking research included 16 Government Affairs and Public Policy executives and managers at 15 leading bio-pharmaceutical, healthcare and medical device companies. Benchmark partners reflect functional experience that interacts directly or indirectly with the Government Affairs function. Because Government Affairs resides in different places across different companies, diverse functions from Government Affairs, Federal Affairs, Communications, Medical Affairs and Public Policy participated in this study. Field interviews and study analysis produced many observations and benchmark findings. Key study insights reflect the inter-related evolution of a company’s commercial structure and how Government Affairs is organized to serve internal and external customers.
Sample Key Findings Differentiated Services Are the Norm for Government Affairs: Almost three-quarters of participants said they vary the level of services – staffing, time, and responsiveness – across internal customers. The practice reflects the significant impact that Government Affairs can have on important business issues such as reimbursement and regulatory. It further underscores how small expert staffs provide services to diverse stakeholders while reflecting differences in stakeholder issues and impact.
Top